Top Markets
Coin of the day
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
Pozycja w akcjach #34153
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
Cena akcji
$0.617
Ostatnia synchronizacja: 2024-10-14
Kapitalizacja rynkowa
$6.13M
Zmiana (1 dzień)
0.49%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Kineta, Inc. (KA)

Kategoria

Historia stopy dywidendy dla Kineta, Inc. (KA)
Stopa dywidendy (TTM) dla Kineta, Inc. (symbol akcji: KA) na dzień 2023-12-31 wynosi: 0.00%
Średnia stopa dywidendy z ostatnich 5 lat: 31.53%
Historia stopy dywidendy dla Kineta, Inc. (KA) od 2015 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
2026 (TTM) 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% -100.00%
2022 157.64% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji